Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged ≥65 years with rheumatoid arthritis
- 31 May 2005
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 27 (5) , 646-656
- https://doi.org/10.1016/s0149-2918(05)00090-1
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Longitudinal Analysis of the Use of Etanercept Versus Infliximab Determined From Medical Chart AuditJournal of Managed Care Pharmacy, 2004
- New Drugs for Rheumatoid ArthritisNew England Journal of Medicine, 2004
- Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: Effect of different methods of case classificationArthritis & Rheumatism, 2003
- Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectivesJournal of Clinical Epidemiology, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987